These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36684852)

  • 41. Impact of morbid obesity on medical expenditures in adults.
    Arterburn DE; Maciejewski ML; Tsevat J
    Int J Obes (Lond); 2005 Mar; 29(3):334-9. PubMed ID: 15685247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between National Heart, Lung, and Blood Institute Weight Guidelines and concurrent medical costs in a manufacturing population.
    Wang F; Schultz AB; Musich S; McDonald T; Hirschland D; Edington DW
    Am J Health Promot; 2003; 17(3):183-9. PubMed ID: 12545586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
    Ara R; Blake L; Gray L; Hernández M; Crowther M; Dunkley A; Warren F; Jackson R; Rees A; Stevenson M; Abrams K; Cooper N; Davies M; Khunti K; Sutton A
    Health Technol Assess; 2012; 16(5):iii-xiv, 1-195. PubMed ID: 22340890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of body mass index, age and gender on current illness: a cross-sectional study.
    Jarrett B; Bloch GJ; Bennett D; Bleazard B; Hedges D
    Int J Obes (Lond); 2010 Mar; 34(3):429-36. PubMed ID: 20010903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis.
    Colao A; Lucchese M; D'Adamo M; Savastano S; Facchiano E; Veronesi C; Blini V; Degli Esposti L; Sbraccia P
    BMJ Open; 2017 Feb; 7(2):e013899. PubMed ID: 28237961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
    Witkowski M; Moreno SI; Fernandes J; Johansen P; Augusto M; Nair S
    Pharmacoeconomics; 2022 Aug; 40(8):751-776. PubMed ID: 35789987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Costs of metabolic syndrome-related diseases induced by obesity in Taiwan.
    Fu T; Wen T; Yeh P; Chang H
    Obes Rev; 2008 Mar; 9 Suppl 1():68-73. PubMed ID: 18307702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body mass index and future healthcare costs: a retrospective cohort study.
    Thompson D; Brown JB; Nichols GA; Elmer PJ; Oster G
    Obes Res; 2001 Mar; 9(3):210-8. PubMed ID: 11323447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moderate and severe obesity have large differences in health care costs.
    Andreyeva T; Sturm R; Ringel JS
    Obes Res; 2004 Dec; 12(12):1936-43. PubMed ID: 15687394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.
    Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2409-2421. PubMed ID: 31749614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity, disease burden, and prescription spending by community-dwelling Medicare beneficiaries.
    Stuart B; Lloyd J; Zhao L; Kamal-Bahl S
    Curr Med Res Opin; 2008 Aug; 24(8):2377-87. PubMed ID: 18616864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The future costs of cancer attributable to excess body weight in Brazil, 2030-2040.
    Rezende LFM; Malhão TA; da Silva Barbosa R; Schilithz AOC; da Silva RCF; Moreira LGM; Machado PAN; Arguelhes BP; Melo MELD
    BMC Public Health; 2022 Jun; 22(1):1236. PubMed ID: 35729550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis.
    Edson-Heredia E; Anderson S; Guo J; Zhu B; Malatestinic WN; Wine-Lee L; Swanson E
    Adv Ther; 2021 Jul; 38(7):3948-3961. PubMed ID: 34091866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population.
    Dai D; Samiian A; Fernandes J; Coetzer H
    J Health Econ Outcomes Res; 2022; 9(2):37-46. PubMed ID: 36051002
    [No Abstract]   [Full Text] [Related]  

  • 56. Association between medication supplies and healthcare costs in older adults from an urban healthcare system.
    Stroupe KT; Murray MD; Stump TE; Callahan CM
    J Am Geriatr Soc; 2000 Jul; 48(7):760-8. PubMed ID: 10894314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between body weight and drug costs: An Italian population-based study.
    Degli Esposti E; Sturani A; Valpiani G; Di Martino M; Ziccardi F; Rita Cassani A; Baraccani C; Gentile M; Puglia MG; Degli Esposti L
    Clin Ther; 2006 Sep; 28(9):1472-81. PubMed ID: 17062319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
    Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
    Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct health care costs associated with obesity in Chinese population in 2011.
    Shi J; Wang Y; Cheng W; Shao H; Shi L
    J Diabetes Complications; 2017 Mar; 31(3):523-528. PubMed ID: 27908605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample.
    Wolf AM; Finer N; Allshouse AA; Pendergast KB; Sherrill BH; Caterson I; Hill JO; Aronne LJ; Hauner H; Radigue C; Amand C; Despres JP
    Diabetes Obes Metab; 2008 Dec; 10(12):1248-60. PubMed ID: 18721258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.